Profound Medical (PROF) announced superiority on the prespecified, primary safety endpoint in the Level 1 post-market CAPTAIN randomized controlled trial comparing the TULSA Procedure with robotic ...
Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...
Detailed price information for Profound Medical Corp (PROF-Q) from The Globe and Mail including charting and trades.
Aetna CVS Health began “bundling” prior authorizations for musculoskeletal procedures, as well as for lung, breast, and ...
The 2026 European Association of Urology (EAU) annual meeting featured a late-breaking abstracts session and a presentation by Dr. Laurence Klotz discussing initial perioperative outcomes of CAPTAIN, ...
Annual Congress was host to a renal cell carcinoma abstract session. Dr. David Liu presented results from ZIRCON-X, a post-hoc analysis of the phase 3 ZIRCON study evaluating the potential impact of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results